Novocure Ltd (NASDAQ:NVCR)

202.27
Delayed Data
As of 3:59pm ET
 +5.01 / +2.54%
Today’s Change
55.40
Today|||52-Week Range
220.48
+16.89%
Year-to-Date
Is Novocure Stock Overvalued?
Apr 30 / MotleyFool.com - Paid Partner Content
NovoCure (NVCR) is Overbought: Is A Drop Coming?
Apr 26 / Zacks.com - Paid Partner Content
NovoCure (NVCR) Q1 2021 Earnings Call Transcript
Apr 29 / MotleyFool.com - Paid Partner Content
Analysts Estimate NovoCure (NVCR) to Report a Decline in Earnings: What to Look Out for
Apr 22 / Zacks.com - Paid Partner Content
Why NovoCure (NVCR) Might Surprise This Earnings Season
Apr 28 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close197.26
Today’s open200.04
Day’s range196.00 - 205.80
Volume41,470
Average volume (3 months)943,694
Market cap$21.1B
Data as of 3:59pm ET, 05/05/2021

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+40.72%
P/E ratio2,022.7
Price/Sales38.11
Price/Book43.84

Competitors

----
RMDResmed Inc+0.44+0.23%
MASIMasimo Corp-2.14-0.96%
NVRONevro Corp-4.29-2.59%
Data as of 4:00pm ET, 05/05/2021

Financials

Next reporting dateJuly 29, 2021
EPS forecast (this quarter)$0.01
Annual revenue (last year)$494.4M
Annual profit (last year)$19.8M
Net profit margin4.01%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
St. Helier, Jersey

Forecasts